Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Belón · SciRah

Researcher profile · Semantic Scholar

J. Belón

Share profile

J. Belón — researcher profile on SciRah

h-index: 13
Works: 45
Citations: 836

Most-cited papers

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
R. Hitt, A. López-Pousa, J. Martínez-Trufero, V. Escrig +16 more
2005Journal of Clinical Oncology444 citations Open access
Semantic Scholar
Preliminary results of a phase II study to evaluate gefitinib combined with docetaxel and cisplatin in patients with recurrent and/or metastatic squamous-cell carcinoma of the head and neck
J. Belón, A. Irigoyen, I. Rodríguez, Y. Escobar +6 more
200546 citations
Semantic Scholar
Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC).
R. Hitt, J. Grau, A. López-Pousa, A. Berrocal +6 more
2006Journal of Clinical Oncology39 citations
Semantic Scholar
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma
J. Feliu, M. P. López Álvarez, M. A. Jaraiz, M. Constenla +6 more
200030 citations Open access
Semantic Scholar
Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels.
J. Jiménez-Bonilla, Antonio Maldonado, S. Morales, A. Salud +4 more
2000Clinical Positron Imaging29 citations
Semantic Scholar
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group
J. Feliu, M. Barón, C. García-Girón, E. Espinosa +7 more
1996Cancer27 citations Open access
Semantic Scholar
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
E. Espinosa, S. Morales, P. Borrega, A. Casas +11 more
2004Cancer Chemotherapy and Pharmacology23 citations
Semantic Scholar
Long-term functional and urodynamic results of 50 patients receiving a modified sigmoid neobladder created with a short distal segment.
M. P. Laguna, M. Brenninkmeier, J. Belón, R. Marrero +3 more
2005Journal of Urology18 citations
Semantic Scholar
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
A. Cervantes, A. Villar-Grimalt, A. Abad, A. Antón-Torres +12 more
1993Annals of Oncology18 citations Open access
Semantic Scholar
Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC)
R. Hitt, J. Grau, A. López-Pousa, A. Berrocal +7 more
200516 citations
Semantic Scholar
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
S. Morales, A. Lorenzo, M. Ramos, P. Ballesteros +12 more
2007Cancer Chemotherapy and Pharmacology14 citations
Semantic Scholar
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
S. Morales, A. Lorenzo, M. Ramos, P. Ballesteros +12 more
2003Cancer Chemotherapy and Pharmacology14 citations
Semantic Scholar
A Prospective Randomized Trial of Continuous Infusion 5‐Fluorouracil (5‐FU) Versus 5‐FU Plus Cisplatin in Patients with Advanced Colorectal Cancer A Trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.)
E. Díaz-Rubio, J. Jimeno, A. Antón, E. Aranda +17 more
1992American Journal of Clinical Oncology14 citations
Semantic Scholar
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
J. de Castro, Aurelio Lorenzo, S. Morales, J. Belón +7 more
2005Cancer Chemotherapy and Pharmacology13 citations
Semantic Scholar
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.
J. Feliu, M. P. López Álvarez, M. A. Jaraiz, M. Constenla +6 more
2000Cancer13 citations
Semantic Scholar
A multicenter randomized phase II trial of granulocyte‐colony stimulating factor‐supported, platinum‐based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma
M. Hidalgo, C. Mendiola, J. López-Vega, D. Castellano +6 more
199813 citations Open access
Semantic Scholar
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
J. Feliu, M. Barón, P. Zamora, P. Alfonso +8 more
1997Oncology11 citations
Semantic Scholar
Frequency and Characteristics of Familial Melanoma in Spain: The FAM-GEM-1 Study
I. Márquez-Rodas, M. Martín González, E. Nagore, C. Gómez-Fernández +21 more
2015PLoS ONE8 citations Open access
Semantic Scholar
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
M. Barón, E. Espinosa, J. Feliu, A. Ordoñez +7 more
1997Oncology8 citations
Semantic Scholar
Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs.
E. Alba, J. J. Bretón, L. Alonso, G. Paredes +2 more
1992Annals of Oncology8 citations Open access
Semantic Scholar
Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen
R. Mattioli, C. Gridelli, J. Castellanos, A. Duque +10 more
2009Clinical and Translational Oncology5 citations
Semantic Scholar
Biweekly administration of irinotecan (CPT-11), oxaliplatin (OX) and 5-fluorouracil (5-FU) as first-line treatment of advanced or metastatic colorectal cancer (MCRC).
J. Reina, P. Sánchez-Rovira, R. Bernabé, M. Bolaños +5 more
2004Journal of Clinical Oncology4 citations
Semantic Scholar
Phase II Study with Iododoxorubicin in Measurable Advanced Colorectal Adenocarcinoma. Effective Rescue Using Weekly High-Dose 5-Fluorouracil (WFU)
A. Villar-Grimalt, E. Aranda, B. Massutí, J. Belón +5 more
19944 citations
Semantic Scholar
Phase II multicenter study of nonpegylated liposomal doxorubicin (A) and docetaxel (T) as neoadjuvant chemotherapy in patients with stage II - III and inflammatory breast cancer (BC)
R. Andrés, J. García-Bueno, A. Madroñal, J. Mayordomo +6 more
20053 citations
Semantic Scholar
Fractionated high doses (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL)
A. Villar, E. Anton, J. Jimeno, E. Aranda +9 more
19913 citations
Semantic Scholar
A phase II trial of a biweekly schedule of capecitabine (X) plus irinotecan (I) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC)
P. García-Alfonso, G. Pérez-Manga, M. Gonzalez, P. Lopez +6 more
20052 citations
Semantic Scholar
Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC)
G. Manga, M. Méndez, M. Palomero, R. Quibén +1 more
20052 citations
Semantic Scholar
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society).
A. Villar-Grimalt, E. Aranda, B. Massutí, J. Belón +5 more
1994Tumori2 citations
Semantic Scholar
Vascular endothelial growth factor receptor-2 (VEGFr-2) genetic polymorphisms as predictors to antiangiogenic therapy.
J. M. Jurado, J. A. Ortega, P. Iglesias, J. García-Puche +1 more
2016Journal of Clinical Oncology1 citations
Semantic Scholar
Phase II study of neoadjuvant docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC)
G. Pérez-Manga, M. Méndez, M. Palomero, R. Quibén +1 more
20071 citations
Semantic Scholar
Study of vascular endothelial growth factor (VEGF) serial blood levels as predictor of response to chemotherapy.
A. Irigoyen, J. Delgado, P. Ballesteros, I. Rodríguez +6 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)
E. González-Flores, R. Luque, J. Valdivia, V. Conde +6 more
20031 citations
Semantic Scholar
Phase II trial of gemcitabine-UFT-leucovorin (ILV) in advanced carcinoma of the pancreas: preliminary results
J. Feliu, J. M. Vincent, J. Dorta, M. Constenla +6 more
19991 citations
Semantic Scholar
A phase II study of weekly 48 hours infusion with high-dose Fluorouracil (FU) in colorectal cancer
E. Aranda, E. Díaz-Rubio, C. Camps, C. Fernández-Marto +8 more
19941 citations
Semantic Scholar
Weekly First-Line Chemotherapy of Metastatic Breast Cancer with Cyclophosphamide and Epirubicin
E. Alba, E. Blanco, E. Aranda, R. Lasso +5 more
1992Tumori1 citations
Semantic Scholar
Familial melanoma in Spain: Preliminary report of the FAM-GEM-1 study.
M. Martín-González, P. Cerezuela, A. Martín-Carnicero, T. Puértolas +7 more
20130 citations
Semantic Scholar
Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
P. Khosravi-Shahi, M. Méndez, R. Quibén, I. Palomero +4 more
20080 citations
Semantic Scholar
Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC).
G. Manga, M. Méndez, M. Palomero, R. Quibén +1 more
2006Journal of Clinical Oncology0 citations
Semantic Scholar
Comparing Cisplatin Plus Fluorouracil to Paclitaxel , Cisplatin , and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
R. Hitt, A. López-Pousa, J. Martínez-Trufero, V. Escrig +16 more
20060 citations
Semantic Scholar
A phase II trial of capecitabine (X) and irinotecan (I), in a biweekly schedule, for patients (Pts) with advanced/metastatic colorectal cancer (MCRC).
P. García-Alfonso, C. gonzález-arenas, E. González-Flores, M. Molina +6 more
2004Journal of Clinical Oncology0 citations
Semantic Scholar
60: Urodynamic Behaviour of a Sigmoid Neobladder (Short Distal Detubularized Sigmoid
M. P. Laguna, S. Isorna, J. Belón, R. Marrero +2 more
20040 citations
Semantic Scholar
274 Neoadjuvant treatment of metastatic liver disease with raltitrexed and oxaliplatin in colorectal cancer patients
F. García-Arroyo, J. García-Bueno, M. Constenia, C. Vadell +6 more
20030 citations
Semantic Scholar
A multicenter randomized Phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma. PSAMOMA Cooperative Group, Spain.
M. Hidalgo, C. Mendiola, J. López-Vega, D. Castellano +6 more
1998Cancer0 citations
Semantic Scholar
Question and Answer Session
L. C. Hock, A. Villalon, Lilia M. B. De Guzman, Marie Cherry Lynn C. Samson +26 more
19970 citations
Semantic Scholar
Contents, Supplement 1, 1997
L. C. Hock, A. Villalon, Lilia M. B. De Guzman, Marie Cherry Lynn C. Samson +26 more
19970 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Barón×10
Invite
M. Barón — researcher profile on SciRah
M. Méndez×8
Invite
M. Méndez — researcher profile on SciRah
J. Feliu×6
Invite
J. Feliu — researcher profile on SciRah
J. Lizón×6
Invite
J. Lizón — researcher profile on SciRah

×5

Invite

A. Antón — researcher profile on SciRah

H. Cortés-Funés×5

Invite

H. Cortés-Funés — researcher profile on SciRah

Invite

J. Dorta — researcher profile on SciRah

Invite

E. Blanco — researcher profile on SciRah

Invite

E. Aranda — researcher profile on SciRah

Invite

R. Hitt — researcher profile on SciRah

A. López-Pousa×4

Invite

A. López-Pousa — researcher profile on SciRah

A. Cervantes×4

Invite

A. Cervantes — researcher profile on SciRah